Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery.
about
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
P2860
Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@en
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@nl
type
label
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@en
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@nl
prefLabel
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@en
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@nl
P2093
P2860
P356
P1476
Preclinical Biodistribution an ...... x after Subcutaneous Delivery.
@en
P2093
Christopher M Jay
Connor Phalon
Courtney Evans
Donald D Rao
John Nemunaitis
Neil Senzer
Padmasini Kumar
Zhaohui Wang
P2860
P304
P356
10.1093/TOXSCI/KFW223
P577
2016-11-04T00:00:00Z